Henry Schein (HSIC) Business & Investor Dossier

Henry Schein makes money by distributing dental and medical products and services to healthcare practitioners. The company operates two segments. Health Care Distribution (the large majority of revenue) distributes dental supplies (impression materials, anesthetics, disposables, small equipment), dental large equipment (chairs, X-ray units, digital imaging systems, CAD/CAM systems), medical supplies and pharmaceuticals to physician offices and ambulatory care facilities, and animal health products (veterinary supplies). Henry Schein is the middleman between product manufacturers (dental device companies, pharmaceutical companies, medical device makers) and the independent dental offices, specialty practices, physician practices, and ambulatory surgery centers that buy those products. The distributor earns the margin between manufacturer wholesale prices and the prices practitioners pay. Technology and Value-Added Services (the smaller, higher-margin segment) offers practice management software through Henry Schein One, a business unit that provides dental practice management, electronic health records, patient communication, analytics, and related technology products to dental offices. Software generates more predictable, recurring subscription revenue compared to product distribution.

In October 2023, Henry Schein disclosed that it had suffered a cyberattack that significantly disrupted its North American operations. The attack was attributed to the ALPHV/BlackCat ransomware group, which later claimed responsibility and threatened to release stolen data. Henry Schein's e-commerce and some operational systems were taken offline as a precaution, preventing customers from placing orders through the company's website and disrupting distribution operations for several weeks. This was particularly damaging because dental offices rely on just-in-time ordering from distributors like Henry Schein -- practices maintain minimal inventory and expect frequent deliveries. The operational disruption caused significant revenue deferral in the fourth quarter of 2023. Then, in late November 2023, Henry Schein disclosed a second cybersecurity incident, further extending the recovery period. The company estimated the incident cost approximately $250 million in revenue deferral, with some of that revenue recovered in subsequent quarters. The attack also led to an employee data breach. The incident raised questions about cybersecurity practices at healthcare distributors, which handle sensitive practitioner and patient billing information.

Henry Schein competes in dental distribution primarily against Patterson Companies (the second-largest dental distributor, also publicly traded as PDCO) and Benco Dental (the third-largest, privately held). Together, Henry Schein, Patterson, and Benco have historically controlled approximately 85-90% of the full-service dental distribution market in the United States. This concentrated market structure reflects the high value of the integrated distribution model: full-service distributors offer not just product delivery but also equipment installation and repair, sales consultant relationships, financing, and technology support, which smaller or online-only competitors cannot easily replicate. Henry Schein's competitive advantages include its broad product catalog, field sales force that visits dental offices and builds relationships, service technicians who install and service dental equipment, and its technology platform (Henry Schein One) that creates additional stickiness once a practice adopts the software. In 2018, the DOJ intervened in the dental supplies market, alleging that Henry Schein, Patterson, and Benco had conspired to boycott buying groups that aggregated independent practices to negotiate lower prices -- the case was later settled.

Henry Schein One is a dental technology business created in 2018 as a joint venture combining Henry Schein's technology businesses with those of Patterson Companies (the venture was later unwound) and has since become a standalone Henry Schein business unit. It offers dental practice management software (Dentrix, Eaglesoft, Easy Dental), patient communication tools, analytics, and connected technology products designed to run and grow a dental practice. The technology segment is strategically important beyond its direct contribution to Henry Schein's financials for several reasons. It creates switching costs: a dental practice that uses Henry Schein's software is deeply integrated into Henry Schein's ecosystem, making it more likely to continue buying supplies from Henry Schein (the core distribution business) to maintain workflow integration. It generates recurring subscription revenue that is more predictable and higher-margin than product distribution. And it positions Henry Schein to capture value as dental practices adopt digital technology (digital imaging, chairside CAD/CAM milling, 3D printing, tele-dentistry) -- as the technology provider, Henry Schein can steer practices toward compatible equipment and consumables it distributes.

Henry Schein's main risks include: dental market cyclicality, as elective dental procedures (cosmetic dentistry, elective orthodontics) are discretionary and decline during economic downturns when patients defer non-essential care -- COVID-19 demonstrated this acutely when dental offices closed for months in early 2020; cybersecurity and operational disruption risk, as demonstrated by the 2023 ALPHV attack that cost hundreds of millions in deferred revenue and required months of recovery; competition from group purchasing organizations and dental service organizations (DSOs), as large dental chains (like Aspen Dental and Heartland Dental) that aggregate many practices under corporate ownership negotiate directly with manufacturers, bypassing distributors like Henry Schein; Amazon Business and direct-to-practice supply models threatening the distribution margin in commodity consumables; regulatory risk in European markets where Henry Schein has significant dental distribution operations with different regulatory frameworks; and customer concentration, as large DSOs represent a growing share of dental practices and can negotiate harder on pricing.